First Public Notice of the Environmental Impact Assessment for the New Product Line Project of Yichang Tianren Pharmaceutical Co., Ltd.
Release date:
2021-12-28
Project Overview: The project leverages existing production lines in the plant’s API manufacturing facility to add five new products: Arbidol hydrochloride, Ambrisentan, Glycine, Solifenacin succinate, and Tadalafil. Specifically, Arbidol hydrochloride and Tadalafil will be produced on Production Line 3 of the existing API workshop; Glycine will be manufactured on Production Line 2 of the same facility; and Ambrisentan and Solifenacin succinate will be produced on Production Line 4. The project employs a batch‑type production process and makes use of the plant’s existing facilities, including the administrative building, Class A chemical storage, Class C warehouse, and tank farm.
I. Project Name and Overview
Project Name: Yichang Tianren Pharmaceutical Co., Ltd. New Production Variety Project
Construction Entity: Yichang Tianren Pharmaceutical Co., Ltd.
Construction Site: No. 509, Donglin Road, Bio-Industry Park, Yichang Area, China (Hubei) Pilot Free Trade Zone
Nature of the project: Expansion
Project Overview: The project leverages existing production lines in the plant’s API manufacturing facility to introduce five new products, namely Arbidol hydrochloride, Ambrisentan, Glycine, Solifenacin succinate, and Tadalafil. Specifically, Arbidol hydrochloride and Tadalafil will be produced on Production Line 3 of the existing API workshop; Glycine will be manufactured on Production Line 2 of the same workshop; and Ambrisentan and Solifenacin succinate will be produced on Production Line 4 of the existing API workshop. The project employs a batch‑type production process and makes use of the plant’s existing facilities, including the administrative building, Class A chemical storage, Class C warehouse, and tank farm.
II. Name and Contact Information of the Project Undertaking Unit
Construction Entity: Yichang Tianren Pharmaceutical Co., Ltd.
Address: No. 509, Donglin Road, Bio-Industry Park, Yichang Area, China (Hubei) Pilot Free Trade Zone
Contact: Engineer Wang
Phone: 18986778831
E-mail: 422685230@qq.com
III. Project Environmental Impact Assessment Agency and Contact Information
Name of the environmental impact assessment agency undertaking the project: Hubei Huisen Ecological Technology Development Co., Ltd.
Address: No. 519-4, Juxiang Road, Yichang Area, China (Hubei) Pilot Free Trade Zone
Contact: Engineer Chen
Phone: 15571717037
E-mail: 710868035@qq.com
IV. Online Link to the Public Opinion Form
The “Public Opinion Form” is attached. If the attachment cannot be opened properly, please click the following web link:
http://www.mee.gov.cn/xxgk2018/xxgk/xxgk01/201810/t20181024_665329.html. The content and format of the public opinion form are prescribed by the Ministry of Ecology and Environment.
V. Main Methods for the Public to Submit Comments
Communicate with the project owner through face-to-face meetings, written comments, email, telephone, and other means.
Attachment: Public Opinion Form for the New Production Variety Project of Yichang Tianren Pharmaceutical Co., Ltd. .docx
Note: The content of this public notice is provided by the project developer; this website assumes no responsibility for its completeness or authenticity.
Public Opinion Form for Environmental Impact Assessment of Construction Projects.doc
Related News
Leave a Message Online
Consultation Service Hotline
Address: No. 509, East Lin Road, Bio-Industrial Park, High-tech Zone, Yichang City, Hubei Province, China
International Marketing Department
Contact: Vivian Guo
Email: Vivian.guo@tianrenpharm.com
Phone: 86-15997560212
WhatsApp: +86-15997560212
Website Development:China Enterprise Dynamics Yichang right of privacy
This website supports both IPv4 and IPv6 bidirectional access.